← Back to Clinical Trials
Recruiting NCT06659497

NCT06659497 The Level of Infertility Distress and Fertility Readiness of Women

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06659497
Status Recruiting
Phase
Sponsor Duzce University
Condition Infertility
Study Type INTERVENTIONAL
Enrollment 90 participants
Start Date 2024-03-15
Primary Completion 2025-04-15

Eligibility & Interventions

Sex Female only
Min Age 23 Years
Max Age 40 Years
Study Type INTERVENTIONAL
Interventions
web-based patient education

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 90 participants in total. It began in 2024-03-15 with a primary completion date of 2025-04-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The infertility treatment process is a multidisciplinary teamwork involving different professional groups. Especially the Controlled Ovarian Hyperstimulation (COH) protocols applied during the infertility treatment process require good nursing education, close monitoring and effective counseling. The patient's education during this process, the development of self-administration skills and follow-up are the responsibility of the infertility nurse and directly affect the treatment process and its success. There is a need to determine the level of impact of infertile individuals on this process, to increase their knowledge level regarding the treatment process and to ensure that individuals are supported closely and strengthened during the treatment process. This study was planned as a randomized controlled experimental study to determine the effect of web-based training to be given to women who undergo Intrauterine Insemination (IUI) treatment on the level of impact of infertility and fertility readiness of women.

Eligibility Criteria

Inclusion Criteria: * Those who applied to Düzce University Health Application and Research Center Infertility Polyclinic between 15.03.2024-15.08.2024, * Primary infertility, * Those who are planned to use Controlled Ovarian Hyperstimulation (COH) in intrauterine insemination (IUI) treatment, * Those who have the equipment (mobile phone, computer, tablet, internet, etc.) to access web-based education, * Those who do not have a chronic disease, * Those who do not have a diagnosed psychiatric disease, * Those who agree to participate in the study, * Those who have the ability to understand and comprehend the questionnaires Exclusion Criteria: * Those who are not planned to use Controlled Ovarian Hyperstimulation (COH) in intrauterine insemination (IUI), * Those who give up on treatment, * Those who have 3 or more graff follicle development on the day of insemination (treatment cancellation), * Those who have 1 million or less sperm obtained on the day of insemination (treatment cancellation)

Contact & Investigator

Central Contact

Hilal Karadeniz

✉ hilalkaradeniz1993@hotmail.com

📞 05386924993

Frequently Asked Questions

Who can join the NCT06659497 clinical trial?

This trial is open to female participants only, aged 23 Years or older, up to 40 Years, studying Infertility. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06659497 currently recruiting?

Yes, NCT06659497 is actively recruiting participants. Contact the research team at hilalkaradeniz1993@hotmail.com for enrollment information.

Where is the NCT06659497 trial being conducted?

This trial is being conducted at Center, Turkey (Türkiye), Düzce, Turkey (Türkiye).

Who is sponsoring the NCT06659497 clinical trial?

NCT06659497 is sponsored by Duzce University. The trial plans to enroll 90 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology